Product information

Nucala 100 mg
100 mg
mepolizumab
3434750
2.58 / 10
Locked

Product properties

R03DX09
GlaxoSmithKline Trading Services
Powder for solution for injection
€863.01
EU/1/15/1043/001
05400571001041
M42
Public
487724-01

Pharmacist Assessment

Structurally fluctuating availability

This product has chronically fluctuating availability (current 2.58/10, historical 🔒/10). Be prepared for possible supply issues and consider keeping an alternative in stock.

No available alternative found in the system. Consult the physician for a therapeutic alternative.
Note: commercialization of this product will be stopped on 01/01/2027.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 7 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Planned
From 01/01/2027

Replacement by another medicinal product/pack

Alternative available
Available Active
Until 31/12/2026

Composition

4 ingredients

Substance Type Strength CAS
Active ingredient
100 mg
Excipient
Excipient
Excipient

Additional information

Availability statistics

Available
0 days
3
0